| Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
| Recovery of motor function | |||||
|
Systematic review |
1228 people 5 RCTs in this analysis |
Proportion of people with incomplete recovery
end of trial
73/625 (11%) with antivirals 95/603 (16%) with placebo |
RR 0.71 95% CI 0.48 to 1.05 P = 0.08 |
Not significant | |
|
Systematic review |
631 people included in the 2 largest trials in the review 2 RCTs in this analysis Subgroup analysis |
Proportion of people with incomplete recovery
end of trial
101/303 (33%) with antivirals 91/328 (28%) with placebo |
RR 1.14 95% CI 0.80 to 1.62 P = 0.48 |
Not significant |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.